Thursday, June 04, 2026
Section
E-paper
Home
Bangladesh
Crime
Laws & Rights
Education
Dhaka
Politics
Weather
Campus
Accidents
Business
Economy
Banks
Commerce
Stock Market
Real Estate
World
Asia
South Asia
Africa
Middle East
Europe
North America
Sport
Cricket
Football
Tennis
Athletics
Formula One
Other Sports
Opinion
Op-Ed
Editorial
Longform
Tribune Z
Magazine
Showtime
Financial
D2
Science, Technology & Environment
Around the Web
Interviews and Dialogue
Brief
Photo
Magazine Archive
Archive
DT TUBE
Live
Thursday, June 04, 2026
Thursday, June 04, 2026
E-paper
বাংলা
Search
Facebook
Twitter
Pinterest
YouTube
LinkedIn
Instagram
Google News
Today's Paper
E-Paper
Archive
Home
E-paper
News
Bangladesh
Dhaka
Education
Election
Foreign Affairs
Nation
Politics
Weather
Campus
Accidents
Business
Economy
Banks
Commerce
Stock Market
Real Estate
World
Asia
South Asia
Africa
Middle East
Europe
North America
Sport
Cricket
Football
Tennis
Athletics
Formula One
Other Sports
Opinion
Op-Ed
Editorial
Longform
Showtime
D2
Magazine
More
Tribune Z
Science, Technology & Environment
Around the Web
Interviews and Dialogue
Brief
Photo
Magazine Archive
Archive
বাংলা
Home
Topic
Johnson & Johnson
Johnson & Johnson
Johnson & Johnson
J&J says its Covid vaccine effectively combats Delta variant
Bangladesh clears Johnson & Johnson’s single-dose Covid-19 vaccine for use
Biden to send 20 million doses of US-authorized vaccines abroad for first time
DGHS: Renata wants to import Moderna Covid-19 vaccine
US ends J&J Covid-19 vaccine pause; shots to resume immediately
Experts: South African coronavirus variant more dangerous, unpredictable
J&J finds problem with Covid vaccine batch
Johnson & Johnson set to begin delivering Covid-19 vaccines to Europe
World's first Covax jab injected as US eyes J&J rollout
FDA staff: Johnson & Johnson's one-shot Covid-19 vaccine effective and safe
J&J's Covid-19 vaccine 66% effective in large global trial
J&J's Covid-19 vaccine should hopefully show over 80% effectiveness
J&J starts two-dose trial of its Covid-19 vaccine candidate
J&J plans to test its Covid-19 vaccine in ages 12-18 soon
AstraZeneca, J&J vaccine trials back on track in US
Johnson & Johnson pauses Covid-19 vaccine trial as participant becomes ill
Brazil approves human trials for potential J&J Covid-19 vaccine
US steps up Covid-19 vaccines, therapies development
Johnson & Johnson drops skin-whitening creams
Johnson & Johnson ordered to pay $4.69 billion damages in talc cancer case
More
লোডিং...
About
Popular Links
x